Unlisted
Stock Code: 003190
| Company Name | 주식회사 알바이오 |
| English Name | R Bio CO., LTD. |
| Business Reg. No. | 1028130395 |
| CEO | 최경호 |
| Address | 서울특별시 금천구 가산디지털2로 98 (가산동, IT캐슬) 2동 305호 |
| Industry | 그 외 기타 의료용품 및 의약 관련제품 제조업 |
| Industry Code | 21100 |
| Established | 19610705 |
| Phone | 02-874-0686 |
| Website | www.rbio.co.kr |
| Regular Employees | 93persons |
| Corp. Reg. No. | 1101110006448 |
Venture Certified
| 신기술기업(고도기술수반산업) | 2005-12-20 ~ 2007-12-19 | 051137032102007 | 2005-12-20 |
| 기술평가보증기업(기금) | 2009-04-10 ~ 2010-04-09 | 20090103178 | 2005-12-20 |
| 혁신성장유형 | 2023-06-07 ~ 2026-06-06 | 20230607030017 | 2005-12-20 |
Revenue CAGR +104.6%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 219B | 140B | 52B |
| Operating Profit | -46B | -87B | -104B |
| Net Profit | -141B | -201B | -202B |
| Total Assets | 446B | 490B | 880B |
| Total Liabilities | 336B | 270B | 507B |
| Total Equity | 110B | 220B | 373B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -46B
3 Consecutive Years of Net Loss
Debt Ratio Surge (+184pp YoY)
▲ 128.0%
▲ 52.0%
▲ 83.9%
▲ 137.1%
▼ 76.6%
| Name | Position | Role |
|---|---|---|
| 최경호 | 사내이사 | 연구개발 |
| 강성근 | 사내이사 | 연구개발 |
| 변대중 | 사내이사 | 법무 |
| 이항영 | 사내이사 | 연구개발 |
| 이승택 | 사외이사 | 경영 |
| 문흥안 | 감사 | 감사 |
| NPS Subscribers | 123persons |
| CEO | 최경호 |
| Est. Avg. Annual Salary | 4,21910K (35210K/mo) |
| Hired (12 mo) | +25persons |
| Left (12 mo) | -16persons |
| Net Change (12 mo) | +9persons |
| NPS Join Date | 1999-09-01 |
| Patent Title | Applicant | Application No. | Filing Date | Status |
|---|---|---|---|---|
| 아임계 이산화탄소를 이용하여 스피큘 내 리포좀을 함침시키는 방법 | 주식회사 에스알바이오텍 | 1020240077747 | 2024-06-14 | 등록 |
| 이미다조피리딘 또는 이미다조피라진 화합물, 이의 제조 방법, 약학 조성물 및 용도 | 상하이 에스아이엠알 바이오테크놀로지 컴퍼니 리미티드 | 1020257039094 | 2024-04-24 | 공개 |
| 대마 식혜 및 이의 제조 방법 | 농업회사법인 (주)헴프앤알바이오|국립경국대학교 산학협력단 | 1020240052969 | 2024-04-19 | 공개 |
| 흑미강 생물전환산물을 유효성분으로 포함하는 암 및 암 관련 피로 개선용 조성물 | (주)에스티알바이오텍|주식회사 엘스케이 | 1020240043903 | 2024-04-01 | 공개 |
| 흑미강 생물전환산물을 유효성분으로 포함하는 호중구감소증의 예방 또는 치료용 조성물 | (주)에스티알바이오텍|주식회사 엘스케이 | 1020240043904 | 2024-04-01 | 공개 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
2 Additional Data Sources
{
"address": "서울특별시 금천구",
"ceo_name": "최경호",
"certificate": [
{
"cert_number": "051137032102007",
"changes": "",
"disclosure_date": "2005-12-20",
"first_cert_date": "2005-12-20",
"no": "1",
"type": "신기술기업(고도기술수반산업)",
"valid_period": "2005-12-20 ~ 2007-12-19"
},
{
"cert_number": "20090103178",
"changes": "",
"disclosure_date": "2009-04-10",
"first_cert_date": "2005-12-20",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2009-04-10 ~ 2010-04-09"
},
{
"cert_number": "20230607030017",
"changes": "대표자",
"disclosure_date": "2023-06-07",
"first_cert_date": "2005-12-20",
"no": "3",
"type": "혁신성장유형",
"valid_period": "2023-06-07 ~ 2026-06-06"
}
],
"company_name": "주식회사 알바이오",
"financials": {
"2022": {
"capital_stock": 64076170000,
"cost_of_sales": 4446145000,
"current_assets": 15195060000,
"current_liabilities": 32721164000,
"gross_profit": 796031000,
"net_income": -20200000000,
"net_income_bs": -20200000000,
"non_current_assets": 72793792000,
"non_current_liabilities": 17973017000,
"non_operating_expenses": 16802806000,
"non_operating_income": 6990475000,
"operating_profit": -10387669000,
"revenue": 5242176000,
"sga_expenses": 11183700000,
"total_assets": 87988852000,
"total_equity": 37294671000,
"total_liabilities": 50694181000
},
"2023": {
"capital_stock": 66596169000,
"cost_of_sales": 9442659000,
"current_assets": 11042593000,
"current_liabilities": 7650656000,
"gross_profit": 4569711000,
"net_income": -20133300000,
"net_income_bs": -20171946000,
"non_current_assets": 37992201000,
"non_current_liabilities": 19374791000,
"non_operating_expenses": 24800934000,
"non_operating_income": 13390429000,
"operating_profit": -8722795000,
"revenue": 14012370000,
"sga_expenses": 13292506000,
"total_assets": 49034794000,
"total_equity": 22009347000,
"total_liabilities": 27025447000
},
"2024": {
"capital_stock": 68096170000,
"cost_of_sales": 14455853000,
"current_assets": 16599370000,
"current_liabilities": 12853429000,
"gross_profit": 7493509000,
"net_income": -14096564000,
"net_income_bs": -14121262000,
"non_current_assets": 27972938000,
"non_current_liabilities": 20758917000,
"non_operating_expenses": 10845168000,
"non_operating_income": 1335861000,
"operating_profit": -4587257000,
"revenue": 21949362000,
"sga_expenses": 12080766000,
"total_assets": 44572308000,
"total_equity": 10959962000,
"total_liabilities": 33612346000
}
},
"industry": "그 외 기타 의료용품 및 의약 관련제품 제조업",
"investment": [],
"phone": "02-6978-****",
"source": "pg_migration"
}{
"address": "서울특별시 금천구 가산디지털2로",
"brno": "102813****",
"cappedWarning": false,
"companyName": "주식회사 알바이오",
"estimatedAvgAnnualSalary": 42190356,
"estimatedAvgMonthlySalary": 3515863,
"fetchedAt": "2026-03-05T11:22:09.124Z",
"industryCode": "154903",
"industryName": "건강 보조용 액화식품 제조업",
"joinDate": "19990901",
"last12MonthsHired": 25,
"last12MonthsLeft": 16,
"last12MonthsNetChange": 9,
"leaveDate": null,
"monthlyPensionAmount": 41082860,
"monthlyTrend": [
{
"lostSubscribers": 16,
"newSubscribers": 25,
"yearMonth": null
}
],
"npsRateUsed": 0.095,
"npsUpperCap": 6370000,
"seq": "6635330",
"status": "1",
"styleCode": "1",
"subscriberCount": 123,
"turnoverMonths": 1
}Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | DART | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | DART | Collected |
| Employment | DART | Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| Venture System Detail | 2026-03-05 | Collected |
| nps | 2026-03-05 | Collected |
| DART Financial | 2026-02-27 | Collected |
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |